PhD candidate in Pharmaceutical Sciences (Synthetic and Natural Products) at the School of Pharmaceutical Sciences of Ribeirão Preto University of São Paulo (USP-SP). Holds a Bachelor's degree in Industrial Chemistry from the Federal University of Uberlândia (UFU-MG), including an academic internship at Saint Mary's University in Canada. Also trained as an Electrotechnician at the Federal Institute of Education, Science and Technology of Goiás (IFG-GO). Has professional experience in the pharmaceutical industry, with a focus on analytical method development. Specialized in Quality Control and Analytical Development through a postgraduate program at the Catholic Universitarian Center Ítalo Brasileiro (Ítalo-SP). Currently engaged in the search for new compounds with potential activity against infectious diseases. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Trypanosomiasis, caused by the unicellular protozoan parasites Trypanosoma cruzi, poses significant economic obstacles to human well-being. Chagas disease is a devastating illness in the Americas. Existing drugs for the treatment of these diseases are insufficient, toxic, prone to parasite resistance, and require parenteral administration. DNDi has identified a series of 3,5-diarylpyrazol…
| 1 / 1 | Ongoing scholarships in Brazil |
| Associated processes | |
CV Lattes
ORCID